Vocal Biomarker Market to Remain Lucrative During 2027
Demand for vocal biomarkers is primarily driven by mounting incidences of neurological, psychological, and various other ailments that impact speech such as Parkinson's disease, depression, and attention deficit & disruptive behavior disorders. According to WHO, nearly 350 Mn individuals across the globe suffered from depression in 2016. The Parkinson's disease Foundation's estimates slated nearly 10 Mn patients with the disease worldwide in 2016. High prevalence of these disorders are expected to significantly rub off on demand and sales of vocal...
View full press release